Survodutide: Dual GLP-1/Glucagon Peptide for Obesity and MASH Explained
Obesity and liver disease are two of the fastest-growing health challenges worldwide. While GLP-1 drugs like semaglutide (Ozempic®, Wegovy®) have changed the landscape of weight-management, researchers are now looking for next-generation therapies that go beyond appetite...